Little Green Pharma Ltd (ASX: LGP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Little Green Pharma Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Little Green Pharma Ltd (ASX: LGP)
Latest News
Share Gainers
Why is the Little Green Pharma (ASX:LGP) share price in the green today?
Cannabis Shares
Little Green Pharma (ASX:LGP) share price leaps 7% on revenue growth
Healthcare Shares
How did ASX healthcare shares perform in the FY22 first quarter?
Cannabis Shares
Little Green Pharma (ASX:LGP) share price lifts as bosses reflect on a big year
Cannabis Shares
The Little Green Pharma (ASX:LGP) share price has fallen 7% this month
ASX Share Market News
What's going wrong for ASX cannabis shares lately?
ASX Share Market News
Why the Little Green Pharma (ASX:LGP) share price has lost 20% since July
ASX Share Market News
What's happening with the Little Green Pharma (ASX:LGP) share price today?
Cannabis Shares
Blazing it? How the top ASX cannabis shares performed in FY21
Share Gainers
These 3 ASX biotech shares are all up at least 120% in a year
Cannabis Shares
Why the Little Green Pharma (ASX:LGP) share price fired up 8% today
Cannabis Shares
Here's why the Little Green Pharma (ASX:LGP) share price is down 5%
LGP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Little Green Pharma Ltd
Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. Its medicines are cultivated, without pesticides, in a hydroponic facility. The company was founded in 2017 and is headquartered in West Perth, Australia.
LGP Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 09 Sep 2026 | $0.07 | $0.00 | 0.00% | 340,320 | $0.07 | $0.07 | $0.06 |
| 08 Sep 2026 | $0.07 | $0.00 | 0.00% | 320,585 | $0.07 | $0.07 | $0.07 |
| 07 Sep 2026 | $0.07 | $0.00 | 0.00% | 380,156 | $0.07 | $0.07 | $0.07 |
| 04 Sep 2026 | $0.07 | $0.00 | 0.00% | 474,754 | $0.06 | $0.07 | $0.06 |
| 03 Sep 2026 | $0.06 | $0.00 | 0.00% | 146,785 | $0.06 | $0.07 | $0.06 |
| 02 Sep 2026 | $0.06 | $0.00 | 0.00% | 13,775 | $0.06 | $0.06 | $0.06 |
| 01 Sep 2026 | $0.06 | $0.00 | 0.00% | 455,953 | $0.07 | $0.07 | $0.06 |
| 31 Aug 2026 | $0.07 | $0.00 | 0.00% | 298,622 | $0.07 | $0.07 | $0.06 |
| 28 Aug 2026 | $0.07 | $0.00 | 0.00% | 514,787 | $0.07 | $0.07 | $0.07 |
| 27 Aug 2026 | $0.07 | $0.00 | 0.00% | 135,260 | $0.07 | $0.07 | $0.07 |
| 26 Aug 2026 | $0.07 | $0.00 | 0.00% | 453,873 | $0.07 | $0.07 | $0.06 |
| 25 Aug 2026 | $0.07 | $0.00 | 0.00% | 81,780 | $0.07 | $0.07 | $0.07 |
| 24 Aug 2026 | $0.07 | $0.00 | 0.00% | 173,886 | $0.07 | $0.07 | $0.07 |
| 21 Aug 2026 | $0.07 | $0.00 | 0.00% | 80,777 | $0.07 | $0.07 | $0.07 |
| 20 Aug 2026 | $0.07 | $0.00 | 0.00% | 128,200 | $0.07 | $0.07 | $0.07 |
| 19 Aug 2026 | $0.07 | $0.00 | 0.00% | 56,033 | $0.07 | $0.07 | $0.07 |
| 18 Aug 2026 | $0.07 | $0.00 | 0.00% | 189,409 | $0.07 | $0.08 | $0.07 |
| 17 Aug 2026 | $0.07 | $0.00 | 0.00% | 187,666 | $0.08 | $0.08 | $0.07 |
| 14 Aug 2026 | $0.07 | $0.00 | 0.00% | 609,208 | $0.08 | $0.08 | $0.07 |
| 13 Aug 2026 | $0.08 | $0.00 | 0.00% | 115,704 | $0.07 | $0.08 | $0.07 |
| 12 Aug 2026 | $0.07 | $0.00 | 0.00% | 37,965 | $0.07 | $0.07 | $0.07 |
| 11 Aug 2026 | $0.08 | $0.00 | 0.00% | 177,960 | $0.08 | $0.08 | $0.07 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 01 Jun 2026 | Michael Lynch-Bell | Buy | 300,000 | $25,500 |
Conversion of securities.
|
| 01 Jun 2026 | Michael Lynch-Bell | Exercise | 300,000 | $25,500 |
Conversion of securities.
|
| 01 Jun 2026 | Paul Long | Cancelled | 3,000,000 | $255,000 |
Cancellation of securities. 1,000,000 rights
|
| 28 May 2026 | Fleta Solomon | Sell | 8,404 | $790 |
On-market trade.
|
| 26 May 2026 | Fleta Solomon | Sell | 5,000 | $475 |
On-market trade.
|
| 26 Feb 2026 | Michael Lynch-Bell | Exercise | 140,000 | $15,400 |
Conversion of securities. 300,000 rights
|
| 26 Feb 2026 | Michael Lynch-Bell | Buy | 140,000 | $15,400 |
Conversion of securities.
|
| 26 Feb 2026 | Neale Fong | Exercise | 70,000 | $7,700 |
Conversion of securities. 150,000 rights
|
| 26 Feb 2026 | Neale Fong | Buy | 70,000 | $7,700 |
Conversion of securities.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael David Lynch-Bell | Non-Executive ChairmanNon-Executive Director | Nov 2018 |
Mr Lynch-Bell has experience as corporate finance executive and consultant. Mr Lynch-Bell Ernst & Young career was focused on auditing clients within the oil and gas sectors and later added mining to his portfolio. Mr Lynch-Bell has been involved advising companies on fundraising, reorganisations, transactions, corporate governance as well as IPOs. He is a member of the Risk committee.
|
| Mr Paul Long | Chief Executive OfficerManaging Director | Aug 2023 |
Mr Long has expertise in the global medicinal cannabis sector and the capital markets. Mr Long worked as a consultant in enterprise health, health technology, and retail pharmaceutical sectors. Mr Long was a former Chief Executive Officer of Onsite Health Solutions.
|
| Mr Seth Yakatan | Non-Executive Director | Jun 2026 |
--
|
| Mr Thomas Huppert | Non-Executive Director | Jun 2026 |
--
|
| Mr Brent Dennison | Non-Executive Chairman | Jun 2026 |
--
|
| Mr Alistair Warren | Company Secretary | Jul 2020 |
-
|
| Ms Paula Butler | Chief Financial Officer | Jun 2026 |
-
|
| Paula Butler | Chief Financial Officer |
-
|
|
| Alistair Warren | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| UBS Nominees Pty Ltd | 34,388,475 | 11.24% |
| Thorney International Pty Ltd | 22,690,049 | 7.42% |
| Ms Fleta Jennifer Solomon | 20,723,216 | 6.78% |
| Barbright Australia Pty Ltd <Interquartz> Super <A/C> | 13,732,793 | 4.49% |
| BNP Paribas Nominees Pty Ltd Acf Clearstream | 7,333,346 | 2.40% |
| HSBC Custody Nominees (Australia) Limited | 6,480,007 | 2.12% |
| Mr Angus Caithness | 5,751,441 | 1.88% |
| Banquo Consulting Pty Ltd | 5,413,333 | 1.77% |
| Netwealth Investments Limited <Wrap> Services <A/C> | 5,348,533 | 1.75% |
| CG Nominees (Australia) Pty Ltd | 4,147,061 | 1.36% |
| Two Willows Pty Ltd <Two> Willows Superfund <A/C> | 3,861,000 | 1.26% |
| Citicorp Nominees Pty Limited | 3,430,231 | 1.12% |
| Jasforce Pty Ltd | 2,883,878 | 0.94% |
| Mr Suwandi Broto + Mrs Siew Broto | 2,826,015 | 0.92% |
| Finclear Services Pty Ltd <Superhero> Securities <A/C> | 2,523,287 | 0.82% |
| Mr Paul Frederick Long <The> Long <A/C> | 2,426,191 | 0.79% |
| Ms Jenny Lorraine Mckay <J> & K Mckay Family <A/C> | 2,189,746 | 0.72% |
| H & K Properties Pty Ltd | 2,000,000 | 0.65% |
| Mr Michael David Lynch-Bell | 1,968,450 | 0.64% |
| FSG (Holding) Pty Ltd | 1,916,000 | 0.63% |